1967 - 2007
Specialty clinical pathology laboratory
1967
Creation of Laboratoire Cerba (Centre d’études et de recherches en biologie appliquée): a reference lab that performs clinical pathology on behalf of other public and private laboratories.
1990
Creation of Cerba’s anatomocytopathology department
1992
Creation of Cerba’s human genetics department
1998
Merge with the infectiology expert Institut Pasteur's specialized clinical pathology centre
Pasteur-Cerba began the first european specialized clinical pathology laboratory
1999
COFRAC Accreditation EN CEI ISO 17025: Cerba, first laboratory accredited in France.
2001
Creation of Cerba’s vet health department
2002
Development of Cerba’s activities in Africa and Middle East
2007
New activity and new geographic position: routine activity and clinical trials in Belgium
2007
Acquisition of Barc Group, clinical pathology leader in Belgium and clinical trials’ global player.
Acquisition of CRI and LBS laboratories in Belgium
Cerba becomes Cerba European Lab
2009 - 2014
New activity and new geographic positions: routine activity in France and Luxembourg
2009
Acquisition of Laboratoire Biolille
2010
Acquisition of Biotop and CBCV
2011
Acquisition of Bioréunion, Ketterthill, BioPyrénéesLab and Medic Lab laboratories.
2012
Acquisition of Biobaie and Biopole 80
2013
Acquisition of CBM 76
Cerba is the first specialized clinical pathology laboratory in France to perform screening tests for trisomy 13, 18 and 21 by free circulating DNA available to the medical community.
Launch of Biopredix, first preventive medicine check-ups to preserve health capital.
Creation of Cerba Specimen Services, branch dedicated to IVD industries.
2014
Acquisition of CMP, anatomocytopatholgy laboratory in Brussels.
2015 - 2016
New activity: veterinary clinical pathology and genetics
Development of Cerballiance network in France
2015
Acquisition of Novescia, Bioponant, laboratoires Goelab, Vigibio, Cerdibio et Labo 17
Cerba European Lab becomes
Cerba HealthCare
Creation of Institut Cerba endowment fund for socially inclusive and responsible clinical pathology
Creation of Cerba Vet, veterinary clinical pathology laboratory.
2016
Launch of Cerba HealthCare University, a pioneering initiative in the clinical pathology market.
Acquisition of Antagene, DNA tests for parentage certification and disease prevention in dogs and cats.
Creation of Cerballiance network bringing together all the routine laboratories in France
Cerba is the first private laboratory to perform exome sequencing and thus committed to the diagnosis of rare constitutional genetic diseases
2017 - 2024
New geographic positions: routine clinical pathology in Africa and Italy
New activity: medical imaging in Italy
Development of routine clinical pathology in France.
Development of clinical trials activities in Netherlands, Canada and Asia.
2017
Acquisition of the Italian laboratories Deltamedica et Fleming Research
2018
Acquisition of BIO 7
Cerba Specimen Services becomes Cerba Xpert
Acquisition of Histalim to strengthen Barc’s expertise in anatomocytopathology
2019
Launch of Cerba Sport, a complete range of tests to optimize sports performance
Creation of Cerba Lancet Africa: Group’s establishment in Africa to develop a network of laboratories in partnership with Lancet Laboratories, South Africa’s leader in clinical pathology
Lauch of Innov Lab, a platform that enables every employee to post ideas, participate in innovation challenges and get informed about ongoing initiatives and new projetcs throughout the Group
2020
Barc, Histalim and Cerba Xpert become Cerba Research, branch dedicated to clinical pathology for clinical trials serving the biotechnology, pharmaceutical and in vitro diagnostics industries.
Creation of Cerba Path, anatomocytopathology experts’ network.
.
2021
Acquisition of the Italian laboratories Lifebrain. Cerba HealthCare becomes the market leader in medical diagnosis in Italy.
Creation of CerbACT Asia (strategic joint-venture between Cerba Research and ACT Genomics) : a purpose-built lab facility in Taiwan covering the Asia Pacific region.
Acquisition of Labexa, a leading clinical pathology group in the Nouvelle Aquitaine region.
Acquisition of Viroclinics-DDL, a fast-growing global virology and immunology contract research organization (CRO).
2022
Acquisition of Yourlab, a clinical pathology group based in western France.
Cerba Lancet Africa signs strategic partnership with International Clinical Laboratories in Ethiopia
Publication of the first CSR report
2023
Animal Diagnostic, IHP VETO, LAPVSO, Orbio et Scanelis join the Cerba Vet centre of excellence
Acquisition of CIRION BioPharma Research (canadian contract research laboratory) to expand the Group’s bioanalytical capabilities and shorten time-to-deploy complex clinical trials
Creation of Cerba HealthCare Saudi Arabia (strategic joint venture between Cerba HealthCare and Nexus Gulf Healthcare) to contribute to the upcoming transformation of healthcare system in Saudi Arabia
2024
Cerba Vet and Antagene join Mars Science & Diagnostics